Use the above evidence to inform your response when relevant. ask cancer commons and tony magliocco of protean...
Ask Navis about your situation
This answer is general. Get one about your specific case — no signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Prostate Cancer — the same guidelines oncologists use.
- Developed under the medical oversight of OpenCancer’s physician-scientist team (Chris Apfel, MD/PhD/MBA, CMO · Kaumudi Bhawe, PhD, CSO).
- Last updated July 27, 2026. Informational only — not a substitute for your oncology team.
Understanding Personalized Testing for Prostate Cancer
I'd be happy to help you understand the resources and experts you're asking about. Let me explain what these organizations and individuals offer for prostate cancer patients.
Tony Magliocco & Protean Biodiagnostics
Who he is: Tony Magliocco, MD, is the President and CEO of Protean Biodiagnostics. He's a medical doctor trained in Canada who spent 20 years as a surgical pathologist and later worked at [facility removed] implementing next-generation sequencing and liquid biopsy technologies.
What Protean Biodiagnostics does: According to the Cancer Patient Lab webinar "The Latest Tests for Personalized Cancer Care & Treatment Decisions," Protean operates a comprehensive system called MAPS that includes:
- Oncology consultation - Expert review of your case
- Diagnostic decision support - Analysis of what tests you've had and identification of gaps in testing
- Clinical trial matching - Help connecting you to relevant clinical trials
- Telemedicine delivery - Remote access to services
- Data integration - Combining tissue pathology and molecular testing results into one comprehensive picture
How it works: Protean reviews your pathology records and [ID removed] to determine if tests were done accurately and identifies any gaps. If gaps exist, they can fill them with additional testing through their CAP/CLIA certified labs (quality-certified laboratories). They create an integrated report for you and your doctor and can monitor you throughout your cancer journey.
Cost: According to the webinar, Protean charges $400 to review your existing data, provide an opinion on what additional testing might be needed, and point toward treatment options.
Key Testing Concepts Magliocco Emphasizes
For prostate cancer specifically, the webinar notes that:
- Liquid biopsy has limitations in detecting resistance to anti-androgen therapy (hormone-blocking treatments)
- Newer methods using RNA analysis can provide deeper profiling
- Companies like Guardant 360 and Tempus offer more comprehensive profiling options
Important distinction: Magliocco emphasizes differentiating between:
- Somatic mutations - Changes in cancer cells only (affect treatment decisions)
- Germ cell mutations - Inherited mutations passed through families (affect future health risks for you and your children)
Genetic counseling is recommended to help you understand these results.
Cancer Commons
While the specific webinar excerpts provided don't detail Cancer Commons extensively, it's worth noting that Cancer Commons is listed among authoritative sources for evidence-based cancer information and is recognized as a trusted resource for cancer patients seeking personalized treatment guidance.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation — no signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Prostate Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with diagnosis for Prostate Cancer patients
Have your records handy? Upload them for a deeper, personalized analysis →